Graduate Medical Education - Resident Programs | Medical Students

RESEARCH PROJECTS: continued

"ASSENT" Trial: Duke Research Institute Principal Investigator, Botsford General Hospital: R. Stomel, D.O.

"SYMPHONY" Trial: Duke Research Institute Principal Investigator, Botsford General Hospital: R. Stomel, D.O.

"AIR PAMI" Trial: Principal Investigator, Botsford General Hospital: R. Stomel, D.O.

"AMIOVIRT" (Amiodarone vs. ICD Randomized Trial): Principal Institution: Botsford General Hospital Primary Investigator: R. Stomel, D.O.

"CAST" (Cardiac Arrhythmia Suppression Trial): New England Journal of Medicine: Principal Institution: Henry Ford Hospital Primary Investigator: R. Stomel, D.O.

Diltiazem SR, Harris Laboratories Inc.: "A randomized, double-blind, placebo controlled trial to determine the safety and efficacy of sustained release dilitazem. Principal Investigator, Botsford General Hospital, R. Stomel, D.O.

Ethmozine, DuPont Merck Pharmaceutical Co. Study DuP 313-519 "Evaluation of Efficacy and safety of Ethmozine in patients with symptomatic paroxysmal atrial fibrillation/flutter": Primary Investigator, Botsford General Hospital: R. Stomel, D.O.

Study DuP 313-520 "Evaluation of efficacy and safety of Ethmozine in patients with symptomatic supraventricular tachyarrhyrthmia (PSVT): Primary Investigator, Botsford General Hospital: R. Stomel, D.O.

"Long-Term Safety Evaluation of Ethmozine in patients with symptomatic PAF/PSVT": Principal Investigator: B. Pitt, M.D.
Co-Investigator: R. Stomel, D.O. Research Projects Continued >

Objectives and Goals

Method of selection of fellowship candidates

Description of Training Sites

Sample Programs

Research Projects